Replacing a Legacy Lab System Without Disrupting the Operations That Depended on It

A high-growth life sciences company preparing for commercial launch and a potential public offering. The company's laboratory systems were central to every major function of the business, making any replacement effort a high-stakes, cross-functional program that required careful planning and execution.

  • Industry: Life Sciences / Diagnostics

  • Size: ~200 employees; significant growth projected

  • Ownership: Venture-backed, private, planning for IPO

Business Challenge

The company's Laboratory Information Management System (LIMS) had been in place for nearly 20 years. Heavy customization had made it deeply integrated with instruments, custom databases, and downstream workflows. It handled critical functions across R&D, manufacturing, and assay services. As the company scaled toward commercial operations, the system's technical debt had become a constraint: it could not support the volume, process complexity, or data architecture required for a commercially-operating business.

Replacing a system this embedded carries real operational risk. A poorly managed LIMS transition can halt laboratory operations, corrupt data, and undermine the quality and regulatory compliance the business depends on. The company needed a program leader who could manage the technical, operational, and organizational dimensions of the replacement simultaneously.

  • Outdated LIMS, heavily customized and integrated with instruments, databases, and downstream workflows

  • Significant technical debt limiting the system's ability to support commercial-scale sample volumes and process complexity

  • Replacement required coordination across R&D, manufacturing, and assay services functions simultaneously

  • System integrator management and requirements facilitation needed across multiple technical and functional sub-teams

  • High operational risk if go-live readiness was not carefully managed

Our Approach & Solution

CIO Source provided program leadership for a new LIMS selection and full replacement implementation over a multi-year engagement. The work spanned project planning and scheduling, system integrator oversight, requirements facilitation across R&D and manufacturing functions, risk and issue management, and executive status reporting covering status, costs, schedule, functionality, and contingency usage.

CIO Source worked with technology and business leadership to maintain an end-to-end view of the program across all sub-teams, ensuring that interdependencies were identified and managed rather than left to surface at go-live. Operational readiness planning ensured the organization could sustain laboratory operations through the transition and support the new platform after go-live.

Business Results & Outcomes

  • Delivered structured program governance covering schedule, budget, risk, and operational readiness

  • Coordinated multiple sub-teams spanning R&D, manufacturing, and assay services

  • Managed system integrator delivery against defined requirements and milestones throughout the program

  • Produced operational readiness plans enabling the organization to sustain laboratory operations through go-live

  • Replaced an outdated, heavily customized platform with a modern system capable of supporting commercial-scale sample processing

  • Delivered consistent executive visibility into status, cost, and contingency usage across the program

Executive Takeaway

Replacing a laboratory system that has been at the core of operations for years requires as much attention to process change and organizational readiness as it does to technical execution. CIO Source provided the program leadership structure that kept a complex, multi-team implementation on track and positioned the organization to sustain its operations through the transition to a modern, scalable platform.

Next
Next

vCIO and IT Transformation: Building a Commercially-Ready IT Function for a Biotech Company on a Path to Market